Damodaran S, Zhao F, Deming DA, Mitchell EP, et al. Phase II Study of Copanlisib in Patients With Tumors With PIK3CA Mutations: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1F. J Clin Oncol 2022;40:1552-1561.
PMID: 35133871